Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-26-294457
Filing Date
2026-07-02
Accepted
2026-07-02 16:02:52
Documents
19

Document Format Files

Seq Description Document Type Size
1 S-3 d141328ds3.htm S-3 307397
2 EX-4.5 d141328dex45.htm EX-4.5 309237
3 EX-4.7 d141328dex47.htm EX-4.7 95774
4 EX-4.8 d141328dex48.htm EX-4.8 97585
5 EX-4.9 d141328dex49.htm EX-4.9 85257
6 EX-5.1 d141328dex51.htm EX-5.1 25284
7 EX-23.1 d141328dex231.htm EX-23.1 2121
8 EX-FILING FEES d141328dexfilingfees.htm   iXBRL EX-FILING FEES 36532
9 GRAPHIC g141328dsp152.jpg GRAPHIC 5335
10 GRAPHIC g141328g01k03.jpg GRAPHIC 36228
  Complete submission text file 0001193125-26-294457.txt   1180134

Data Files

Seq Description Document Type Size
22 EXTRACTED XBRL INSTANCE DOCUMENT d141328dexfilingfees_htm.xml XML 17110
Mailing Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462
Business Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462 8584103134
INOVIO PHARMACEUTICALS, INC. (Filer) CIK: 0001055726 (see all company filings)

EIN.: 330969592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-297233 | Film No.: 261150903
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)